Nvidia, T-Mobile US, Vivos Therapeutics, SoFi Technologies, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Vivos Therapeutics shares surged 47.50% to close at $4.13, after hitting an intraday high of $5.95 and a low of $3.02. The stock’s 52-week high is $48.79, and its 52-week low is $1.91. The FDA granted 510 (k) clearance to the company’s flagship oral medical device, poised to disrupt the pediatric sleep apnea market.